Trademarkia Logo

Canada

C$
RYZNEUTA design
APPROVED

on 27 Mar 2025

Last Applicant/ Owned by

EVIVE BIOTECHNOLOGY (SHANGHAI) LTD.

FLOOR 3, BUILDING 1NO. 400 FANGCHUN ROADCHINA (SHANGHAI) PILOT FREETRADE ZONE, SHANGHAI 201207

CN

Serial Number

1961890 filed on 9th May 2019

RYZNEUTA design

Trademark usage description

chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment of stroke, spinal injury and Read More

Classification Information


Class [005]
Chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment of stroke, spinal injury and neurodegenerative diseases; chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment of neurological disorders, namely, amyotrophic lateral sclerosis; chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases; Chemical pharmaceutical preparations used for stimulating white blood cell production; human medicines for the treatment of stroke, spinal injury and neurodegenerative diseases; human medicines for the treatment of neurological disorders, namely, amyotrophic lateral sclerosis; human medicines for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases; human medicines used for stimulating white blood cell production; biochemical drugs for the treatment of stroke, spinal injury and neurodegenerative diseases; biochemical drugs for the treatment of neurological disorders, namely, amyotrophic lateral sclerosis; biochemical drugs for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases; biochemical drugs used for stimulating white blood cell production; pharmaceutical preparations used for stimulating white blood cell production; pharmaceutical preparations for the treatment of stroke, spinal injury and neurodegenerative diseases; pharmaceutical preparations for the treatment of neurological disorders, namely, amyotrophic lateral sclerosis; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases; medical chemical preparations in the nature of chemical preparations for medical purposes for the treatment of stroke, spinal injury and neurodegenerative diseases; medical chemical preparations in the nature of chemical preparations for medical purposes for the treatment of neurological disorders, namely, amyotrophic lateral sclerosis; medical chemical preparations in the nature of chemical preparations for medical purposes for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases; medical chemical preparations used for stimulating white blood cell production; medical biological preparations for the treatment of stroke, spinal injury and neurodegenerative diseases; medical biological preparations for the treatment of neurological disorders, namely, amyotrophic lateral sclerosis; medical biological preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases; medical biological preparations used for stimulating white blood cell production; medical ointments, namely, medicated ointments for the treatment of stroke, spinal injury and neurodegenerative diseases; medical ointments, namely, medicated ointments for the treatment of neurological disorders, namely, amyotrophic lateral sclerosis; medical ointments, namely, medicated ointments for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases; medical ointments used for stimulating white blood cell production; medical drugs for the treatment of stroke, spinal injury and neurodegenerative diseases; medical drugs for the treatment of neurological disorders, namely, amyotrophic lateral sclerosis; medical drugs for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases; medical drugs used for stimulating white blood cell production; diagnostic reagents for the treatment of stroke, spinal injury and neurodegenerative diseases; diagnostic reagents for the treatment of neurological disorders, namely, amyotrophic lateral sclerosis; diagnostic reagents for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases; diagnostic reagents used for stimulating white blood cell production.


Classification kind code

11

Mark Details


Serial Number

1961890

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 135
on 18th Feb 2025
Amendment to Application
Submitted for opposition 15
on 12th Aug 2024
Correspondence Created
Submitted for opposition 22
on 23rd Nov 2023
Search Recorded
Submitted for opposition 20
on 23rd Nov 2023
Examiner's First Report
Submitted for opposition 287
on 11th Apr 2022
Pre-Assessment Letter Sent
Submitted for opposition 135
on 28th Jul 2021
Amendment to Application
Submitted for opposition 135
on 10th Jun 2020
Amendment to Application
Submitted for opposition 31
on 13th May 2019
Formalized
Submitted for opposition 30
on 9th May 2019
Filed
Submitted for opposition 1
on 9th May 2019
Created